this pressed for the record: Ebola Should Change How We Fund Drugs for Emerging Disease | TIME

“The big pharma companies are not in the business of charity”

An worker inspects the Nicotiana benthamiana plants at Medicago greenhouse in Quebec City

More

See How Ebola Drugs Grow In Tobacco Leaves

Fear, Misinformation, and Social Media Complicate Ebola Fight

Ebola Outbreak Could Cost West Africa’s Economy $32.6 Billion

Emerging and infectious diseases are having a moment for all the worst reasons, with credit due to the Ebola outbreak. But scientists studying other emerging diseases beyond Ebola are hopeful that the attention on the disease—and what can happen without available therapeutics—is here to stay.

via Ebola Should Change How We Fund Drugs for Emerging Disease | TIME.

Leave a Reply: (What... You're shy?)

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s